The Ministry of Healreactive, a system to measure the glucose in key blood to calibrate your medication.Before the measure, the product cost 0.45 euros.The general director of Pharmacy, José Clerigues, estimated that the recipe fertilizer will mean savings to public coffers of 34%.
Clerigues revealed this data in an email sent to the management and financial departments of the main public hospitals of the community, to which the country had access.
The estimate and gesture sat like a jug of cold water among the representatives of the 800,000 Valencians suffering from the disease, according to the Diabetes prevalence study.The president of the Federation of Diabetics of the Valencian Community (Fedicova), Mercedes Sánchez, lamented the attitude of the Consell and warned of its consequences among the patients with less resources."Sounding 50 euros every two months, which is what this treatment costs, can be a dispensation for those who earn 400 euros," he said.And censored the Clerican mail."It cannot be proud that the Generalitat gets chest of a cut."The copayment affects patients who control their disease with insulin injections, 6% of the total, according to Fedicova.
An expert in health management pointed out the "danger" that the co -payment relaxes the control of the sick and causes complications in the future."In a few months there could be more diabetics in emergencies, which would mean that the Government would have left the cylinder head," said this specialist who works for the Valencian Health Agency.
It cannot be proud that the Generalitat gets chest from a cut
PSPV deputy Ignacio Subías urged health to reveal the medical consequences of implementing co -payment to diabetics.
From the Ministry of the mail of the Director General of Pharmacy was removed.Health recalled that the Generalitat achieved in June "a saving of eight million" by renegotiating with the laboratories the acquisition of reactive strips.With the agreement, each container has a price for the Valencian Health Agency of 21.95 euros, according to a spokeswoman of the department directed by Luis Rosado.
Treating a diabetes patient (3,000 euros per year) costs twice as much as the rest of the patients and is an expense of 1.8 billion a year, according to Fedicova.